Depreciation of TENAX THERAPEUTICS, INC. from 31 Oct 2012 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
TENAX THERAPEUTICS, INC. quarterly and annual Depreciation in USD history and change rate from 31 Oct 2012 to 30 Sep 2024.
  • TENAX THERAPEUTICS, INC. Depreciation for the quarter ending 30 Sep 2024 was $0, a 100% decline year-over-year.
  • TENAX THERAPEUTICS, INC. Depreciation for the twelve months ending 30 Sep 2024 was $6,570, a 53% increase year-over-year.
  • TENAX THERAPEUTICS, INC. annual Depreciation for 2023 was $7,570, a 47% increase from 2022.
  • TENAX THERAPEUTICS, INC. annual Depreciation for 2022 was $5,143, a 25% increase from 2021.
  • TENAX THERAPEUTICS, INC. annual Depreciation for 2021 was $4,116, a 0.96% increase from 2020.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

TENAX THERAPEUTICS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $6,570 $0 -$1,000 -100% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $7,570 $1,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $7,570 $895 $0 0% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $7,570 $4,675 +$3,285 +236% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2024 2023 FY
Q3 2023 $4,285 $1,000 -$200 -17% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $4,485 $1,000 -$200 -17% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $4,685 $895 -$458 -34% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $5,143 $1,390 +$374 +37% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $4,769 $1,200 +$200 +20% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $4,569 $1,200 +$200 +20% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $4,369 $1,353 +$253 +23% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $4,116 $1,016 +$39 +4% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $4,077 $1,000 $0 0% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $4,077 $1,000 $0 0% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $4,077 $1,100 $0 0% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $4,077 $977 -$340 -26% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $4,417 $1,000 -$300 -23% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $4,717 $1,000 -$300 -23% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 $5,017 $1,100 $0 0% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $5,017 $1,317 +$302 +30% 01 Oct 2019 31 Dec 2019 10-K/A 16 Apr 2021 2020 FY
Q3 2019 $4,715 $1,300 -$700 -35% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $5,415 $1,300 -$1,700 -57% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
Q1 2019 $7,115 $1,100 -$1,900 -63% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q4 2018 $9,015 $1,015 -$2,606 -72% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 $11,621 $2,000 -$1,000 -33% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $12,621 $3,000 $0 0% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $12,621 $3,000 -$1,000 -25% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 $13,621 $3,621 -$331 -8.4% 01 Oct 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $13,952 $3,000 -$2,000 -40% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $15,952 $3,000 -$2,000 -40% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $17,952 $4,000 -$1,000 -20% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $18,952 $3,952 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 $5,000 -$7,000 -58% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2017 Q3
Q2 2016 $5,000 -$8,000 -62% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 $5,000 -$12,000 -71% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q3 2015 $60,000 $12,000 -$9,000 -43% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $69,000 $13,000 -$9,000 -41% 01 May 2015 31 Jul 2015 10-Q 09 Sep 2015 2016 Q1
Q1 2015 $78,000 $17,000 -$4,300 -20% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q4 2014 $82,300 $18,000 -$3,000 -14% 01 Nov 2014 31 Jan 2015 10-Q 17 Mar 2015 2015 Q3
Q3 2014 $85,300 $21,000 -$2,000 -8.7% 01 Aug 2014 31 Oct 2014 10-Q 10 Dec 2015 2016 Q2
Q2 2014 $87,300 $22,000 -$1,000 -4.3% 01 May 2014 31 Jul 2014 10-Q 09 Sep 2015 2016 Q1
Q1 2014 $88,300 $21,300 01 Feb 2014 30 Apr 2014 10-K 16 Mar 2017 2016 FY
Q4 2013 $21,000 -$2,000 -8.7% 01 Nov 2013 31 Jan 2014 10-Q 17 Mar 2015 2015 Q3
Q3 2013 $23,000 $0 0% 01 Aug 2013 31 Oct 2013 10-Q 15 Dec 2014 2015 Q2
Q2 2013 $23,000 01 May 2013 31 Jul 2013 10-Q 15 Sep 2014 2015 Q1
Q4 2012 $23,000 01 Nov 2012 31 Jan 2013 10-Q 17 Mar 2014 2014 Q3
Q3 2012 $23,000 01 Aug 2012 31 Oct 2012 10-Q 17 Dec 2013 2014 Q2

TENAX THERAPEUTICS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $7,570 +$2,427 +47% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024 2023 FY
2022 $5,143 +$1,027 +25% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $4,116 +$39 +0.96% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $4,077 -$940 -19% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $5,017 -$3,998 -44% 01 Jan 2019 31 Dec 2019 10-K/A 16 Apr 2021 2020 FY
2018 $9,015 -$4,606 -34% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 $13,621 -$5,331 -28% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
2016 $18,952 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2014 $77,836 -$10,464 -12% 01 May 2014 30 Apr 2015 10-K 16 Mar 2017 2016 FY
2013 $88,300 -$4,659 -5% 01 May 2013 30 Apr 2014 10-K 16 Mar 2017 2016 FY
2012 $92,959 01 May 2012 30 Apr 2013 10-KT 14 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.